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Background and purpose   There are rising concerns about the 
frequency of infection after arthroplasty surgery. Prophylactic 
antibiotics are an important part of the preventive measures. As 
their effect is related to the timing of administration, it is impor-
tant to follow how the routines with preoperative prophylactic 
antibiotics are working.
Methods   In 114 consecutive cases treated at our own univer-
sity clinic in Lund during 2008, the time of administration of pre-
operative prophylactic antibiotic in relation to the start of sur-
gery was recorded from a computerized operation report. In 291 
other cases of primary total knee arthroplasty (TKA), randomly 
selected from the Swedish Knee Arthroplasty Register (SKAR), 
the type and dose of prophylactic antibiotic as well as the time of 
administration in relation to the inflation of a tourniquet and to 
the start of surgery was recorded from anesthetic records. 
Results   45% (95% CI: 36–54) of the patients operated in Lund 
and 57% (CI: 50–64) of the TKAs randomly selected from the 
SKAR received the preoperative antibiotic 15–45 min before the 
start of surgery. 53% (CI: 46–61) received antibiotics 15–45 min 
before inflation of a tourniquet. 
Interpretation   The inadequate timing of prophylactic antibi-
otics indicates that the standards of strict antiseptic and aseptic 
routines in arthroplasty surgery are falling. The use of a simple 
checklist to ensure the surgical safety may be one way of reducing 
infections in arthroplasty surgery. 

Today, there is increasing concern that the number of infec-
tions  in  conjunction  with  arthroplasty  surgery  is  slowly 
rising. At a recent meeting of the Nordic Arthroplasty Asso-
ciation (NARA), Denmark, Norway, and Sweden indicated 
an increase in infections after hip arthroplasty after the year 
2000. Although a similar trend has not been observed for knee 
arthroplasty, it must be kept in mind that the risk of knee infec-
tion is already higher. The figures from the Nordic arthroplasty 
registers  (http://www.jru.orthop.gu.se,  http://www.knee.se, 
http://www.dhr.dk/english.htm, http://www.haukeland.no/nrl/
eng) are well in accordance with a recent study by Pulido et 
al. (2008) who reported an infection rate after hip and knee 
arthroplasty of 0.3% (15 of 5,060) and 1.1% (48 of 4,185), 
respectively (p < 0.001). 
When arthroplasty was introduced in the Nordic countries, 
it was a highly specialized type of surgery with strict anti-
septic and aseptic routines. There was meticulous attention 
paid to antibiotic prophylaxis, outpatient scrubbing (repeated 
by the hospital staff before and at surgery), and checking for 
skin infections and other ongoing infections—and the patient 
was to be admitted to a clean ward, or at least to a clean sin-
gle room, as late as possible before the actual surgery (Lidgren 
and Rasmusson 1973). 
There are indications that the standards have slowly fallen. 
Patients are now often admitted to general wards together with 
other elective and emergency cases, and the wards are often 
overcrowded. This is worrying, considering that there is clear 
evidence that the risk of hospital-acquired infection and bac-
terial resistance increases when bed occupancy is above 90% 
(Marx 2008). Furthermore, arthroplasty surgery is now per-
formed as routine surgery, often by staff with varying levels 
of experience. This “industrialization” has probably made it 
increasingly difficult to constantly maintain important pro-
phylactic routines. 
Antibiotic prophylaxis is important to minimize the risk of 
infection, and the evidence for its use has been growing. A 
recent systematic review (AlBuhairan et al. 2008) of the effec-
tiveness of antibiotic prophylaxis in patients undergoing total 
hip and knee replacement found that antibiotic prophylaxis 
reduced the absolute risk of wound infection by 81% com-
pared with no prophylaxis (p < 0.001) (pooled analysis of 7 
studies; n = 3,065). Furthermore, a study from the Norwegian 634  Acta Orthopaedica 2009; 80 (6): 633–638
Arthroplasty Register on total hip arthroplasties found that 
combining  systemic  antibiotics  with  antibiotic-impregnated 
cement significantly reduced the risk of infection and that the 
combination was superior to the single use of either of these 
prophylactic methods (Engesaeter et al. 2003). 
To ensure that there is an adequate antibiotic concentration 
in the tissues at surgery, the timing of preoperative prophy-
laxis is crucial. For the most commonly used antibiotics, it has 
been considered optimal to administer the drug intravenously 
30 min before skin incision (Gyssens 1999, Polk and Christ-
mas 2000) and it has been documented that administration 
more than 60 min preoperatively is associated with higher risk 
of surgical infection (Galandiuk et al. 1989).
 The importance of antibiotic prophylaxis and its timing is 
illustrated by the fact that in the US, experts in surgical infec-
tion prevention, hospital infection control, and epidemiology 
have developed guidelines for national surveillance and qual-
ity improvement in giving prophylaxis (Bratzler and Houck 
2004). 
In  a  recent  study  of  1,922  consecutive  hip  arthroplasty 
patients  from  11  hospitals,  it  was  found  that  surgical  site 
infection (superficial and deep) occurred in 2.6% of cases. 
The highest odds for infection were found in patients who had 
received prophylaxis after incision, and the authors suggested 
that intervention programs in search of amendable factors to 
prevent  infection  should  focus  on  timely  administration  of 
antibiotic prophylaxis (van Kasteren et al. 2007). 
A small study at our own university clinic in Lund, initi-
ated by a local strategic program against antibiotic resistance, 
indicated that the timing of prophylactic antibiotics was inad-
equate. We decided to study the timing of administration of 
prophylactic antibiotics at our own clinic in greater detail. We 
also examined a sample of knee arthroplasties reported to the 
Swedish Knee Arthroplasty Register (SKAR).
Patients and methods
In 114 consecutive cases treated at our own university clinic 
in Lund during 2008, the time of administration of preopera-
tive prophylactic antibiotic in relation to the start of surgery 
was recorded from the computerized operation report. The 
information was collected without the involvement or knowl-
edge of the staff who administered the prophylactic antibi-
otic. According to local guidelines, patients should have the 
preoperative prophylactic antibiotic 30 min before the start of 
surgery. The time of inflation of a tourniquet was not avail-
able. 
The SKAR contains a restricted number of variables (Rob-
ertsson et al. 2000), and the timing of prophylactic antibiotics 
was not registered before 2009. To search for this informa-
tion, 300 cases were randomly selected from the 9,238 pri-
mary total knee arthroplasties (TKAs) registered in SKAR 
to have been performed due to osteoarthritis during 2007. A 
random-number  generator  was  used.  The  anesthetic  report 
was requested from the operating unit and searched for infor-
mation on the type and dose of prophylactic antibiotic, as well 
as the time of administration in relation to the inflation of a 
tourniquet and to the start of surgery. 
The anesthetic records were unavailable for 9 patients (3%), 
leaving 115 men and 176 women. The mean age at operation 
was 70 (43–90) years. 4 patients had both knees operated on 
the same day and in 3 cases the knee selected for study was 
the first one and in 1 the second. Administration of prophy-
lactic antibiotic more than 45 min before the start of surgery 
was regarded as inadequate because of the short half-life of 
the most commonly used antibiotics. Administration later than 
15 min before the start of surgery was also regarded as inad-
equate, as in most cases the infusion will not have entered the 
circulation at the time of incision; it is definitely too late when 
a tourniquet is used (Tomita and Motokawa 2007).
The 95% confidence interval (CI) for proportion was cal-
culated as ps ± 1.96 times the standard error of ps, where ps is 
the proportion of patients receiving prophylactic antibiotic in 
adequate time.
Results
Of the 114 patients studied in Lund during 2008, only 51 (45%, 
95% CI: 36–54%) received the first antibiotic dose 15–45 min 
before the start of surgery (Figure 1). In 22 cases (19%), sur-
gery was started at the same time or before administration of 
prophylactic antibiotic.
Figure 1. A control chart showing the timing of the first dose of prophy-
lactic antibiotic in relation to the start of surgery at the Department of 
Orthopedics, Lund University Hospital. Each dot represents 1 case. 
Zero represents the start of surgery. The red lines indicate 45 min and 
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 Of the 291 randomly selected TKAs from the Swedish 
Knee Arthroplasty Register, it was possible to get informa-
tion on the type of prophylactic antibiotic administered in 247 
cases (85%). 89% had received cloxacillin. The dose varied 
and there seemed to be no common standard (Table). In 198 
cases (68%), it was possible to ascertain from the anesthetic 
record the time from administration of the prophylactic anti-
biotic until the start of surgery. Only 113 of 198 (57%, CI: 
50–64%) received the antibiotic 15–45 min before the start of 
surgery (Figure 2). The mean time was 41 min, with a range 
from 105 min before the start of operation to 120 min after the 
start. In 176 cases (61%), it was possible to ascertain the time 
from administration of prophylactic antibiotic until the time 
of inflation of a tourniquet. Only 94 of 176 patients (53%, CI: 
46–61%) received antibiotics 15–45 min before the tourniquet 
was applied (Figure 3). The mean time was 40 min, with a 
range from 153 min before the inflation of a tourniquet to 120 
min after inflation.
 In 2 of the 4 bilaterally operated patients, no additional anti-
biotics were given before the start of surgery on the second 
knee.
Discussion
There is good evidence for the use of prophylactic antibiot-
ics to reduce the risk of surgical wound infection (Classen et 
al. 1992, Lidgren 2001, Fletcher et al. 2007, Prokuski 2008) 
and for how preoperative antibiotic prophylaxis should be 
administered. The adherence to recommendations is, how-
ever, not well studied. In our clinic at Lund University Hos-
pital, we found a lack of adherence to prophylactic routines 
with less than 50% of cases receiving antibiotics 15–45 min 
before the start of surgery. The national sample collected 
from the Swedish Knee Arthroplasty Register showed the 
same disturbing result: only 57% had adequate timing of 
antibiotic prophylaxis. 2 of 4 bilaterally operated patients 
did not get a second antibiotic infusion before the second 
knee arthroplasty. This alarming result raises concern about 
the standard of other established measures to reduce the risk 
of infection.
It was recently shown in a non-randomized study that use 
of a simple surgical safety checklist reduced morbidity and 
mortality (Haynes et al. 2009). Interestingly, the surgical site 
infection rate was reduced by almost 50% (p < 0.001). The 
administration of antibiotics within 60 min before incision 
improved from 56% to 83% by use of the safety list. 
The intravenous antibiotic prophylaxis admin-
istered preoperatively in 247 randomly chosen 
TKAs performed in Sweden 2007 
Antibiotic   n   %
 Cloxacillin  
   1 g   54   22
   2 g   158   64
   unknown dose   7   3
 Clindamycin  
   300 mg   1   0.4
  600 mg   23   9
 Cefuroxime
   1.5 g   4   2
Figure 3. The timing of administration of prophylactic antibiotic in rela-
tion to the inflation of a tourniquet in 176 cases of primary TKA. Zero 
represents the start of surgery. The green bars correspond to accept-
able timing. 
Figure 2. The timing of administration of prophylactic antibiotic in rela-
tion to the start of surgery in 198 cases of primary TKA. Zero repre-
sents the start of surgery. The green bars correspond to acceptable 
timing. 
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There are indications from the national registers in Den-
mark, Norway, and Sweden that infection rates after primary 
hip arthroplasty are increasing. Furthermore, the proportion 
of revisions caused by infection is increasing (http://www.
jru.orthop.gu.se, http://www.dhr.dk/english.htm, http://www.
haukeland.no/nrl/default.htm). The reoperation rate because 
of infection within 2 years after a primary hip arthroplasty 
for those operated in Sweden 2004–2007 was 0.6%, and there 
was an unacceptable 10-fold difference when comparing indi-
vidual surgical units in Sweden, with a range of 0.2–2.0% 
(http://www.jru.orthop.gu). The true incidence of infection is 
higher, as some cases are treated with antibiotics only. Some 
low-virulence infections will lead to a slow, progressive loos-
ening and the diagnosis of infection may sometimes be obvi-
ous first at revision with positive cultures often more than 2 
years after surgery. The large differences between clinics can 
only be partially explained by differences in case mix such 
as sex, replacement for hip fracture, rheumatoid arthritis, and 
tumor, all of which have been reported to influence the risk of 
prosthetic infection (http://www.knee.se, Bengtson 1990, Ber-
bari et al. 1998, Gjertsen et al. 2008). 
Thus, the statement in an editorial of this journal in 2001 that 
“joint prosthetic infection is a success story” (Lidgren 2001) 
may not be true any longer. Apart from inadequate adminis-
tration of prophylactic antibiotics, possible reasons might be 
overcrowded wards with mixed patients and lack of focus on 
environmental hygiene measures (Dancer 2008, Patel et al. 
2008). It has been shown that a segregation policy with fenced 
wards results in a reduced infection rate in those undergoing 
elective joint replacement, and also reduces MRSA coloniza-
tion (Biant et al. 2004, Johnston et al. 2005). 
The  first  study  published  on  prophylactic  antibiotics  in 
joint replacements came from Sweden (Ericson et al. 1973) 
and ever since, cloxacillin has been the prophylactic antibi-
otic most used in orthopedic surgery in Sweden. There is a 
lack of recent publications on local resistance patterns, based 
on preoperative screening of nasal carriers and on cultures at 
revision (Sanzén and Walder 1988, Stefánsdóttir et al. 2009), 
to decide whether the antibiotics in current use are effective or 
whether the prophylaxis should be changed.
A factor that is not normally taken into account is the rela-
tively short half-life of cloxacillin (30 min). The half-life of 
cefuroxim is 66 min and that of clindamycin is 144 min. Ear- . Ear-
lier randomized studies on the effect of different regimes often 
used systemic administration of antibiotics either as intrave-
nous  injections  or  (in  the  1970s)  intramuscular  injections. 
Today, a preoperative infusion of antibiotics is often given, 
which may last for up to 30 min although a shorter infusion 
time of 15 min is more common. 
The prophylaxis has least effect when an antibiotic is given 
after  the  application  of  a  tourniquet.  This  means  that  the 
extremity is to a large extent unprotected regarding antibi-
otic prophylaxis, because although local antibiotic-containing 
bone cement is used routinely in knee prostheses in the Nordic 
countries, the antibiotics will only start to leak out slowly from 
the outer surface of bone cement once the tourniquet has been 
released and bleeding starts (Törholm et al. 1983, Lidgren et 
al. 2003). Similarly, there is a considerable reduction in pro-
tection when a patient is given an antibiotic with a short half-
life too early i.e. too long before the operation starts.
The  antibiotic  regimes  typically  recommend  fixed  doses 
of  antibiotics  pre-  and  postoperatively,  with  the  first  post-
operative dose often being administered 6 h after surgery. It 
would probably be more efficient to individually prescribe a 
dose based on body weight and to repeat the dose based on 
the half-life of the antibiotics selected as well as the length 
of the surgical procedure. Thus, one could consider whether 
or not all patients for whom the actual surgical procedure 
takes more than 1 hour should have a new infusion, starting 
just before the tourniquet is released. This is also what the 
AAOS recommends in its recent document on infection pro-
phylaxis (Prokuski 2008). The document states that at twice 
the half-life of the selected antibiotic (counting from the first 
injection), a repeat dose should be given. In knee arthroplasty 
surgery, this very often coincides with the release of the tour-
niquet. One should be aware of the fact that the half-life given, 
for example, for cloxacillin (30 min) is based on studies in 
healthy  individuals  and  microbiology  assays.  Hepatic  bio-
transformation may also induce a slight risk of accumulation 
of penicillins. Furthermore, it is known that patients under-
going hip and knee arthroplasty develop a transient globular 
and tubular dysfunction. However, systemic prophylaxis with 
cloxacillin and bone cement containing gentamycin has not 
been considered to be the cause of this, but rather the surgical 
trauma (Nergelius et al. 1997a,b, 1998, Vinge et al. 1997). 
One way of circumventing some of the difficulties of timing 
in knee surgery would be to use regional antibiotic treatment 
by local intravenous administration in the foot, given prior to 
surgery but after tourniquet application. This has been shown 
to give up to 8 times the tissue concentration compared to sys-
temic administration, but there are no published data on the 
feasibility of adapting it widely in clinical practice (Miller et 
al. 2004). Another way might be to use continuous antibiotic 
infusion during the whole procedure, starting 45 min before 
surgery, and to calculate the speed of infusion (i.e. the amount 
given) based on well-known information such as the serum 
and  tissue profile  of  the  prophylactic  antibiotic(s)  selected, 
and also the age of the patient, their kidney function and BMI, 
and adjust accordingly (Amendola 2000). This would keep the 
patient protected in the case of a hip arthroplasty but would 
only partly solve the problem for knee arthroplasty, as the use 
of a tourniquet is standard today. 
In  a  recent  study  by  Sorian  et  al.  (2008),  900  knee 
arthroplasty patients were randomized between standard anti-
biotic prophylaxis and administration of prophylactic antibi-
otics just before release of the tourniquet. In both the stan-
dard and the experimental group, the patients had a high rate 
of deep infection at three months of follow-up (of 3.4% and Acta Orthopaedica 2009; 80 (6): 633–638  637
1.9%, respectively), but the difference was not statistically 
significant. That particular study raises serious concern about 
the present timing of administration of antibiotic prophylaxis 
in knee arthroplasty. 
Clinical relevance
Our findings show that the timing of preoperative antibiotic 
prophylaxis is inadequate and that the routines must be sharp-
ened. Furthermore, it seems that the literature supports adjust-
ment of doses, timing of injections, and also repeated injec-
tions during lengthy surgical procedures based on the half-
life of the antibiotic(s) selected. We suggest that orthopedic 
clinics should start to use a simple checklist for surgery with 
a standard delay before skin incision, during which (among 
other important considerations) the administration of prophy-
lactic antibiotics is confirmed. As of January 2009, the time of 
administration of preoperative antibiotic has been recorded in 
the Swedish Knee Arthroplasty Register.
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